NEW YORK, July 5, 2011 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:
International Hyaluronic Acid Viscosupplementation Physician Survey
2011
http://www.reportlinker.com/p0567542/International-Hyaluronic-Acid-Viscosupplementation-Physician-Survey-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic
Over 100 orthopedic specialists were surveyed regarding their
perceptions and usage of hyaluronic acid viscosupplementation
during the 2011 American Academy of Orthopaedic Surgeons (AAOS)
conference. This survey report compares usage patters and
perceptions of orthopedic specialists regarding hyaluronic acid
viscosupplement product, including single injection, 3-injection
and 5-injection therapy regimes. Satisfaction with current
offerings is examined in detail, along with the market penetration
of single injection products. The data presented describes practice
experience, practice volume and the attitudes of the respondents to
the product, as well as how these factors interact. In addition to
physician brand preference, this survey report describes the
proportion of doctors who would be willing to switch to a single
injection product like Genzyme’s Synvisc-One®. The results of
the survey indicated a high degree of familiarity with the product
within the physician community. There is a general divide in the
U.S. medical community between HA brands that are used for a
majority of procedures within a practice. The respondents were
asked to rate their satisfaction with the various injection
products. This in term was compared to the probabi
‘/>”/>
SOURCE
